MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

L-732138

CAS No. : 148451-96-1

MCE 站：L-732138

产品活性：L-732138 是一种选择性，有效和竞争性神经激肽-1 (NK-1) 受体拮抗剂，IC₅₀ 为 2.3 nM。L-732138 在克隆的人 NK-1 受体中的效力比在克隆大鼠 NK-1 受体中高 200 倍，比人类 NK-2 和 NK-3 受体高 1000 倍以上。L-732138 可减轻痛觉过敏并具有抗肿瘤作用。

研究领域：GPCR/G Protein  |  Neuronal Signaling

作用靶点：Neurokinin Receptor

In Vitro: L-732138 (0 -100 ?M; first doubling time; COLO 858, MEL HO and COLO 679 cells) treatment results in a concentration-dependent cytotoxicity. L-732138 inhibits cell growth with IC₅₀ of 44.6 μM for COLO 858 cells, 76.3 μM for MEL HO cells and 64.2 μM for COLO 679 cells. L-732138 blocks substance P (SP) mitogen stimulation.
L-732,138 treatment results in a large number of apoptotic cells were found in COLO 858, MEL HO and COLO 679 melanoma cell lines. In DAPI-stained cultures, at IC₅₀ concentration of 43.6% apoptotic cells for the three melanoma cell lines, whereas at IC₁₀₀ concentration of 51.4 % apoptotic cells.

In Vivo: L-732138 (10^-4-10^-2 mol/kg; intravenous injection; for 15 minutes; male Dunkin-Hartley guinea-pigs) treatment abolishes vagally-induced plasma exudation and significantly inhibits the enhancement by LPS. The LPS-enhanced vagally-induced plasma exudation is not completely inhibited by either L-732138 or SOD pretreatment alone, but is blocked by the combination of both pretreatments.

相关产品：Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Neuronal Signaling Compound Library  |  Anti-Cancer Compound Library  |  Neurotransmitter Receptor Compound Library  |  Substance P  |  Aprepitant  |  Netupitant  |  Senktide  |  Fosaprepitant dimeglumine  |  SB-222200  |  Maropitant  |  Vapreotide  |  Neurokinin A TFA  |  Neurokinin B TFA  |  Saredutant  |  Talnetant  |  Vofopitant  |  NKP608  |  [Sar9,Met(O2)11]-Substance P TFA  |  Eprazinone dihydrochloride  |  Y1 receptor antagonist 1  |  Substance P(1-7) TFA  |  GR 159897  |  Men 10376 TFA  |  Neurokinin A(4-10) TFA  |  Osanetant

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。